The First In Human (FIH) study is a long-term, single center, non-randomized study
established by Lombard Medical, Inc. to collect "on-label" data in the clinical setting on
patients undergoing endovascular repair with IntelliFlex™, the latest generation of the
Aorfix™ AAA Flexible Stent Graft Delivery System, for treatment of abdominal aortic and
aorto-iliac aneurysms in anatomy where the aorta in the aneurysm neck is bent through an
angle between 0° and 90°.